Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis.
Miyoshi, Arina, Kameda, Hiraku, Nagai, So, Nakamura, Akinobu, Miya, Aika, Takase, Takahiro, Astumi, Tatsuya, Miyoshi, HideakiJournal:
Journal of Diabetes Investigation
DOI:
10.1111/jdi.13458
Date:
November, 2020
File:
PDF, 8.86 MB
2020